FDA Licenses iRobot to Practice Telemedicine (IRBT)

FDA Licenses iRobot to Practice Telemedicine

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Click Here Now

On Thursday, Roomba and PackBot maker iRobot (NASDAQ: IRBT ) announced it has received 510(k) clearance from the FDA to deploy its new RP-VITA Remote Presence Robot for use in hospitals -- a first in the nascent field of telemedicine.

RP-VITA, a joint project between iRobot and telemedicine "solutions" provider InTouch Health, is described as being a robot featuring "the latest in autonomous navigation and mobility technologies developed by iRobot with state-of-the-art telemedicine and electronic health record integration developed by InTouch Health."

In a press release, iRobot explained that the robot can be used, for example, for remote doctor-to-patient consults, in which "a doctor can visit a patient, and communicate with hospital staff and patients with a single click" on the RP-VITA's onboard iPad control panel. InTouch will be responsible for selling the robot to hospitals. iRobot, meanwhile, will focus on exploring "adjacent market opportunities for robots such as RP-VITA and the iRobot Ava mobile robotics platform."

iRobot shares are up 11.4% on the news, at $23.51.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.